Detalhe da pesquisa
1.
RPL22 is a tumor suppressor in MSI-high cancers and a key splicing regulator of MDM4.
bioRxiv
; 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38106152
2.
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.
Nat Commun
; 13(1): 141, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013146
3.
To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology.
Anticancer Res
; 39(7): 3303-3309, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262850
4.
National Cancer Institute Centers With Environmental Sustainability Plans for Climate Change.
JAMA Netw Open
; 6(6): e2317206, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338908